Agresera

Vannasby, Sweden Founded: 2004 • Age: 22 yrs Acquired By Olink
Primary and secondary antibodies for plant, human and animals

About Agresera

Agresera is a Healthcare company based in Vannasby (Sweden) founded in 2004, and was acquired by Olink in May 2020. Primary and secondary antibodies for plant, human and animals. Its website agrisera.com draws about 29 thousand monthly visits. Agresera offers products and services including Plant/Algal Antibodies, Secondary Antibodies, Compartment Markers, ELISA Kits, and Photosynthesis Antibodies. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is Agrisera AB.

Company details

Agresera was established in 2004 in Vannasby, Sweden, within the biotechnology sector focused on research tools. Primary and secondary antibodies for plant, human, and animal applications are provided, alongside bacterial and fungal antibodies. Rapid western blotting kits and detection reagents are also offered to support laboratory operations in these fields.

  • Headquarters Vannasby, Sweden
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website agrisera.com
  • Social LinkedIn X YouTube
  • Acquired by Olink (May 2020)
  • Legal Name Agrisera Ab
Key Metrics
  • Latest Funding Round
    $1.83M (USD), Grant

    Jul 2018

  • Investors
    Olink

    & 2 more

  • Acquired by
    Olink

    (May 2020)

Products & Services of Agresera

Agresera offers a comprehensive portfolio of products and services, including Plant/Algal Antibodies, Secondary Antibodies, Compartment Markers, ELISA Kits, and Photosynthesis Antibodies.

Plant/Algal Antibodies
Research Tools

Antibodies for detecting plant and algal proteins in studies.

Secondary Antibodies
Detection Reagents

Reagents for enhancing antibody-based assays in biology.

Compartment Markers
Cell Biology Tools

Markers for identifying cellular compartments in plants.

ELISA Kits
Diagnostic Tools

Kits for quantifying hormones and proteins in research.

Photosynthesis Antibodies
Specialized Reagents

Antibodies targeting photosynthesis components like PSI and PSII.

Apps and channels of Agresera

its YouTube channel Agrisera has 231 subscribers.

Agrisera
YouTube 231 subscribers Business & Finance
Open channel

Funding Insights of Agresera

  • Total Rounds 2
  • Last Round Grant β€” $1.83M
  • First Round $241,091

    (May 2016)

  • Investors Count 2

All 2 funding rounds of Agresera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2018$1.83MGrant––
May 2016$241,091Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Agresera

Agresera has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Olink, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Provider of products and services for human protein biomarker research and development
2004olink.comUppsala, Sweden
Premium access

Investor details for Agresera

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Agresera

4 dated milestones of Agresera across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Agresera is founded.
  2. Funding First funding round of $241K.
  3. Funding Latest funding round, Grant, of $1.8M.
  4. Exit Acquired by Olink.

Web traffic of Agresera

The website of Agresera (agrisera.com) receives about 29.3K visits a month.

  • Monthly visits
    29.3K

    ▲ 47.3% vs previous month

Similar websites

Websites whose visitors overlap most with Agresera. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cambridgecapp.wordpress.com
cambridgecapp.wordpress.com
100%
–
seedbiology.de
seedbiology.de
93%
#4,454,062–
bio.net
bio.net
90%
#4,746,645–
cspp-scpv.ca
cspp-scpv.ca
90%
–
sebiology.org
sebiology.org
90%
#835,956–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for Agresera

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Agresera

Premium access

Complete news archive for Agresera

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Agresera

Agresera was founded in 2004 and raised its 1st funding round 12 years after it was founded.

Agresera is headquartered in Vannasby, Sweden. It is registered at Vannasby, Vasterbotten, Sweden.

Agresera was established in 2004 in Vannasby, Sweden, within the biotechnology sector focused on research tools. Primary and secondary antibodies for plant, human, and animal applications are provided, alongside bacterial and fungal antibodies. Rapid western blotting kits and detection reagents are also offered to support laboratory operations in these fields.

Agresera offers Plant/Algal Antibodies, Secondary Antibodies, Compartment Markers, ELISA Kits, and Photosynthesis Antibodies.

Agresera has 3 investors. Key investors include Olink, European Union, and EIC Fund.

Agresera operates through Agrisera Ab.

Yes. Agresera was acquired by Olink in May 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available